NYSE$ABT
Abbott Laboratories · Q4 2025 earnings
Q4 2025 earnings · · Before market open · Investor relations
Briefing
Abbott reported Q4 2025 sales of $11.5B with GAAP EPS of $1.01 and adjusted EPS of $1.50.
Fourth-quarter worldwide sales were $11.5 billion, up 4.4% reported and 3.0% organic. GAAP diluted EPS was $1.01 and adjusted EPS was $1.50 (+12% YoY). Full-year 2025 sales reached $44.3 billion with adjusted EPS of $5.15. 2026 guidance calls for organic sales growth of 6.5–7.5% and adjusted EPS of $5.55–5.80.
- Q4 sales $11.5B (+4.4% reported).
- GAAP EPS $1.01; adjusted EPS $1.50 (+12%).
- FY25 sales $44.3B; adjusted EPS $5.15.
- 2026 adjusted EPS guide $5.55–$5.80.
Headline financials
Revenue & EPS history
Abbott · Revenue · Quarterly
$11.5B
Revenue by segment
Abbott · $6.7B total across 2 segments · Q3 2023
- Medical Devices$4.25B+17.5%63.4%
- Diagnostics$2.45B-33.3%36.6%
Forward guidance
The release discusses Abbott's outlook for upcoming periods, including capital allocation, operating priorities, and market risks, without relying solely on numeric EPS bridges.
Tailwinds
- Abbott cites operational execution and demand trends supporting the outlook.
- Balance sheet and liquidity actions aim to fund growth and shareholder returns.
- Management issued or reiterated forward revenue and EPS targets.
- 2026 organic sales growth guide 6.5–7.5%; adjusted EPS $5.55–$5.80.
Headwinds
- Macro, pricing, and input-cost volatility could pressure margins.
- Segment mix and one-time items may affect quarter-to-quarter comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
+0.6%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+1.1%
Avg return
30 days after
61%
45 / 74 earnings
Positive
+10.3%
Q3 2013
Best reaction
-9.9%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.2% | -8.7% | -16.8% | |
| Q4 2025 | -9.9% | -10.3% | -7.1% | |
| Q3 2025 | -2.9% | -2.8% | -2.0% | |
| Q2 2025 | -0.1% | +1.4% | +3.3% | |
| Q1 2025 | +2.8% | +2.9% | +6.8% | |
| Q4 2024 | +0.8% | +10.8% | +15.5% | |
| Q3 2024 | +1.6% | +0.8% | -0.1% | |
| Q2 2024 | -2.5% | -0.7% | +6.0% | |
| Q1 2024 | -3.6% | -2.0% | -4.7% | |
| Q4 2023 | -1.4% | -0.5% | +4.8% | |
| Q3 2023 | +3.6% | +4.0% | +8.0% | |
| Q2 2023 | +6.5% | +5.3% | -3.3% | |
| Q1 2023 | +6.0% | +6.0% | +4.6% | |
| Q4 2022 | -1.3% | -2.4% | -10.7% | |
| Q3 2022 | -9.3% | -6.4% | -1.1% | |
| Q2 2022 | +0.7% | -1.3% | +0.1% | |
| Q1 2022 | +2.8% | +0.0% | -5.6% | |
| Q4 2021 | -2.3% | +3.4% | -0.7% | |
| Q3 2021 | +4.8% | +6.1% | +6.3% | |
| Q2 2021 | +1.5% | +0.7% | +6.2% | |
| Q1 2021 | -1.5% | -1.0% | -5.4% | |
| Q4 2020 | +4.9% | +6.8% | +4.4% | |
| Q3 2020 | +1.0% | +0.6% | +2.3% | |
| Q2 2020 | +2.6% | +1.5% | +3.4% | |
| Q1 2020 | +5.6% | +3.4% | -1.2% | |
| Q4 2019 | +1.1% | -0.2% | -2.5% | |
| Q3 2019 | +0.5% | -0.4% | +4.5% | |
| Q2 2019 | +5.5% | +5.9% | +1.9% | |
| Q1 2019 | -3.2% | -2.4% | -0.5% | |
| Q4 2018 | -0.9% | -3.4% | +6.5% | |
| Q3 2018 | -4.0% | -3.4% | +1.5% | |
| Q2 2018 | +1.6% | +0.6% | +3.1% | |
| Q1 2018 | +0.1% | -1.6% | +3.2% | |
| Q4 2017 | +6.7% | +6.9% | +0.8% | |
| Q3 2017 | +1.7% | +1.9% | +0.9% | |
| Q2 2017 | +2.9% | +2.8% | -1.4% | |
| Q1 2017 | +1.3% | +1.6% | -0.6% | |
| Q4 2016 | +1.6% | +1.6% | +12.5% | |
| Q3 2016 | -1.0% | -1.8% | -3.2% | |
| Q2 2016 | +3.0% | +3.9% | +5.8% | |
| Q1 2016 | +0.1% | — | — | |
| Q4 2015 | -6.5% | — | — | |
| Q3 2015 | +4.2% | — | — | |
| Q2 2015 | +2.9% | — | — | |
| Q1 2015 | +2.8% | — | — | |
| Q4 2014 | +3.1% | — | — | |
| Q3 2014 | +0.1% | — | — | |
| Q2 2014 | +1.8% | — | — | |
| Q1 2014 | +2.5% | — | — | |
| Q4 2013 | -4.3% | — | — | |
| Q3 2013 | +10.3% | — | — | |
| Q2 2013 | +0.0% | — | — | |
| Q1 2013 | +1.3% | — | — | |
| Q4 2012 | -0.3% | — | — | |
| Q3 2012 | -7.6% | — | — | |
| Q2 2012 | -1.0% | — | — | |
| Q1 2012 | -1.5% | — | — | |
| Q4 2011 | -0.2% | — | — | |
| Q3 2011 | -0.4% | — | — | |
| Q2 2011 | -0.1% | — | — | |
| Q1 2011 | +0.9% | — | — | |
| Q1 2008 | +1.4% | — | — | |
| Q4 2010 | +1.4% | — | — | |
| Q3 2010 | -0.8% | — | — | |
| Q2 2010 | +0.7% | — | — | |
| Q1 2009 | -1.4% | — | — | |
| Q1 2010 | +0.9% | — | — | |
| Q4 2007 | -1.1% | — | — | |
| Q4 2009 | -1.1% | — | — | |
| Q3 2008 | +1.4% | — | — | |
| Q3 2009 | +1.4% | — | — | |
| Q2 2009 | +2.1% | — | — | |
| Q4 2008 | +2.1% | — | — | |
| Q2 2008 | +2.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro